Cost-effectiveness and return on investment of hepatitis C virus elimination in China: A modelling study

Cost-effectiveness and return on investment of hepatitis C virus elimination in China: A modelling study

Background/Aims The World Health Organization set the goal of eliminating hepatitis C virus (HCV) by 2030, with 80% and 65% reductions in HCV incidence and mortality rates, respectively. We aimed to evaluate the health benefits, cost-effectiveness and return on investment (ROI) of HCV elimination. M...

Full description

Saved in:
Bibliographic Details
Main Authors: Meiyu Wu, Jing Ma, Xuehong Wang, Sini Li, Chongqing Tan, Ouyang Xie, Andong Li, Aaron G Lim, Xiaomin Wan
Format: Article
Language:English
Published: Korean Association for the Study of the Liver 2025-04-01
Series:Clinical and Molecular Hepatology
Subjects:
hepatitis c
disease eradication
cost-effectiveness analysis
outcome assessment, health care
china
Online Access:http://e-cmh.org/upload/pdf/cmh-2024-0664.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://e-cmh.org/upload/pdf/cmh-2024-0664.pdf

Similar Items